The global Adalimumab Drug market was valued at million in 2024 and is projected to reach US$ million by 2032, at a CAGR of %during the forecast period.
Adalimumab, sold under the brand name�Humira, among others, is a�monoclonal antibody�used to treat�rheumatoid arthritis,�psoriatic arthritis,�ankylosing spondylitis,�Crohn"s disease,�ulcerative colitis,�plaque psoriasis,�hidradenitis suppurativa,�uveitis, and�juvenile idiopathic arthritis.[23][24][25]�It is administered by�injection under the skin.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
We have surveyed the Adalimumab Drug companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks
This report aims to provide a comprehensive presentation of the global market for Adalimumab Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Adalimumab Drug. This report contains market size and forecasts of Adalimumab Drug in global, including the following market information:
Global Adalimumab Drug market revenue, 2020-2025, 2026-2032, ($ millions)
Global top five Adalimumab Drug companies in 2024 (%)
Total Market by Segment:
Global Adalimumab Drug market, by Type, 2020-2025, 2026-2032 ($ millions)
Global Adalimumab Drug market segment percentages, by Type, 2024 (%)
Adalimumab
Adalimumab Biosimilar
Global Adalimumab Drug market, by Application, 2020-2025, 2026-2032 ($ millions)
Global Adalimumab Drug market segment percentages, by Application, 2024 (%)
Adult
Children
Global Adalimumab Drug market, by region and country, 2020-2025, 2026-2032 ($ millions)
Global Adalimumab Drug market segment percentages, by region and country, 2024 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Adalimumab Drug revenues in global market, 2020-2025 (estimated), ($ millions)
Key companies Adalimumab Drug revenues share in global market, 2024 (%)
Further, the report presents profiles of competitors in the market, key players include:
Cambridge Antibody Technology
BASF
AbbVie
MABURA
Exemptia
Amgen
Sandoz
Boehringer Ingelheim
Mylan
Biogen
Outline of Major Chapters:
Chapter 1: Introduces the definition of Adalimumab Drug, market overview.
Chapter 2: Global Adalimumab Drug market size in revenue.
Chapter 3: Detailed analysis of Adalimumab Drug company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Adalimumab Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Adalimumab Drug Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 Global Adalimumab Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Adalimumab Drug Overall Market Size
2.1 Global Adalimumab Drug Market Size: 2024 VS 2032
2.2 Global Adalimumab Drug Market Size, Prospects & Forecasts: 2020-2032
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Adalimumab Drug Players in Global Market
3.2 Top Global Adalimumab Drug Companies Ranked by Revenue
3.3 Global Adalimumab Drug Revenue by Companies
3.4 Top 3 and Top 5 Adalimumab Drug Companies in Global Market, by Revenue in 2024
3.5 Global Companies Adalimumab Drug Product Type
3.6 Tier 1, Tier 2, and Tier 3 Adalimumab Drug Players in Global Market
3.6.1 List of Global Tier 1 Adalimumab Drug Companies
3.6.2 List of Global Tier 2 and Tier 3 Adalimumab Drug Companies
4 Sights by Product
4.1 Overview
4.1.1 Segmentation by Type - Global Adalimumab Drug Market Size Markets, 2024 & 2032
4.1.2 Adalimumab
4.1.3 Adalimumab Biosimilar
4.2 Segmentation by Type - Global Adalimumab Drug Revenue & Forecasts
4.2.1 Segmentation by Type - Global Adalimumab Drug Revenue, 2020-2025
4.2.2 Segmentation by Type - Global Adalimumab Drug Revenue, 2026-2032
4.2.3 Segmentation by Type - Global Adalimumab Drug Revenue Market Share, 2020-2032
5 Sights by Application
5.1 Overview
5.1.1 Segmentation by Application - Global Adalimumab Drug Market Size, 2024 & 2032
5.1.2 Adult
5.1.3 Children
5.2 Segmentation by Application - Global Adalimumab Drug Revenue & Forecasts
5.2.1 Segmentation by Application - Global Adalimumab Drug Revenue, 2020-2025
5.2.2 Segmentation by Application - Global Adalimumab Drug Revenue, 2026-2032
5.2.3 Segmentation by Application - Global Adalimumab Drug Revenue Market Share, 2020-2032
6 Sights by Region
6.1 By Region - Global Adalimumab Drug Market Size, 2024 & 2032
6.2 By Region - Global Adalimumab Drug Revenue & Forecasts
6.2.1 By Region - Global Adalimumab Drug Revenue, 2020-2025
6.2.2 By Region - Global Adalimumab Drug Revenue, 2026-2032
6.2.3 By Region - Global Adalimumab Drug Revenue Market Share, 2020-2032
6.3 North America
6.3.1 By Country - North America Adalimumab Drug Revenue, 2020-2032
6.3.2 United States Adalimumab Drug Market Size, 2020-2032
6.3.3 Canada Adalimumab Drug Market Size, 2020-2032
6.3.4 Mexico Adalimumab Drug Market Size, 2020-2032
6.4 Europe
6.4.1 By Country - Europe Adalimumab Drug Revenue, 2020-2032
6.4.2 Germany Adalimumab Drug Market Size, 2020-2032
6.4.3 France Adalimumab Drug Market Size, 2020-2032
6.4.4 U.K. Adalimumab Drug Market Size, 2020-2032
6.4.5 Italy Adalimumab Drug Market Size, 2020-2032
6.4.6 Russia Adalimumab Drug Market Size, 2020-2032
6.4.7 Nordic Countries Adalimumab Drug Market Size, 2020-2032
6.4.8 Benelux Adalimumab Drug Market Size, 2020-2032
6.5 Asia
6.5.1 By Region - Asia Adalimumab Drug Revenue, 2020-2032
6.5.2 China Adalimumab Drug Market Size, 2020-2032
6.5.3 Japan Adalimumab Drug Market Size, 2020-2032
6.5.4 South Korea Adalimumab Drug Market Size, 2020-2032
6.5.5 Southeast Asia Adalimumab Drug Market Size, 2020-2032
6.5.6 India Adalimumab Drug Market Size, 2020-2032
6.6 South America
6.6.1 By Country - South America Adalimumab Drug Revenue, 2020-2032
6.6.2 Brazil Adalimumab Drug Market Size, 2020-2032
6.6.3 Argentina Adalimumab Drug Market Size, 2020-2032
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Adalimumab Drug Revenue, 2020-2032
6.7.2 Turkey Adalimumab Drug Market Size, 2020-2032
6.7.3 Israel Adalimumab Drug Market Size, 2020-2032
6.7.4 Saudi Arabia Adalimumab Drug Market Size, 2020-2032
6.7.5 UAE Adalimumab Drug Market Size, 2020-2032
7 Companies Profiles
7.1 Cambridge Antibody Technology
7.1.1 Cambridge Antibody Technology Corporate Summary
7.1.2 Cambridge Antibody Technology Business Overview
7.1.3 Cambridge Antibody Technology Adalimumab Drug Major Product Offerings
7.1.4 Cambridge Antibody Technology Adalimumab Drug Revenue in Global Market (2020-2025)
7.1.5 Cambridge Antibody Technology Key News & Latest Developments
7.2 BASF
7.2.1 BASF Corporate Summary
7.2.2 BASF Business Overview
7.2.3 BASF Adalimumab Drug Major Product Offerings
7.2.4 BASF Adalimumab Drug Revenue in Global Market (2020-2025)
7.2.5 BASF Key News & Latest Developments
7.3 AbbVie
7.3.1 AbbVie Corporate Summary
7.3.2 AbbVie Business Overview
7.3.3 AbbVie Adalimumab Drug Major Product Offerings
7.3.4 AbbVie Adalimumab Drug Revenue in Global Market (2020-2025)
7.3.5 AbbVie Key News & Latest Developments
7.4 MABURA
7.4.1 MABURA Corporate Summary
7.4.2 MABURA Business Overview
7.4.3 MABURA Adalimumab Drug Major Product Offerings
7.4.4 MABURA Adalimumab Drug Revenue in Global Market (2020-2025)
7.4.5 MABURA Key News & Latest Developments
7.5 Exemptia
7.5.1 Exemptia Corporate Summary
7.5.2 Exemptia Business Overview
7.5.3 Exemptia Adalimumab Drug Major Product Offerings
7.5.4 Exemptia Adalimumab Drug Revenue in Global Market (2020-2025)
7.5.5 Exemptia Key News & Latest Developments
7.6 Amgen
7.6.1 Amgen Corporate Summary
7.6.2 Amgen Business Overview
7.6.3 Amgen Adalimumab Drug Major Product Offerings
7.6.4 Amgen Adalimumab Drug Revenue in Global Market (2020-2025)
7.6.5 Amgen Key News & Latest Developments
7.7 Sandoz
7.7.1 Sandoz Corporate Summary
7.7.2 Sandoz Business Overview
7.7.3 Sandoz Adalimumab Drug Major Product Offerings
7.7.4 Sandoz Adalimumab Drug Revenue in Global Market (2020-2025)
7.7.5 Sandoz Key News & Latest Developments
7.8 Boehringer Ingelheim
7.8.1 Boehringer Ingelheim Corporate Summary
7.8.2 Boehringer Ingelheim Business Overview
7.8.3 Boehringer Ingelheim Adalimumab Drug Major Product Offerings
7.8.4 Boehringer Ingelheim Adalimumab Drug Revenue in Global Market (2020-2025)
7.8.5 Boehringer Ingelheim Key News & Latest Developments
7.9 Mylan
7.9.1 Mylan Corporate Summary
7.9.2 Mylan Business Overview
7.9.3 Mylan Adalimumab Drug Major Product Offerings
7.9.4 Mylan Adalimumab Drug Revenue in Global Market (2020-2025)
7.9.5 Mylan Key News & Latest Developments
7.10 Biogen
7.10.1 Biogen Corporate Summary
7.10.2 Biogen Business Overview
7.10.3 Biogen Adalimumab Drug Major Product Offerings
7.10.4 Biogen Adalimumab Drug Revenue in Global Market (2020-2025)
7.10.5 Biogen Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Adalimumab Drug Market Opportunities & Trends in Global Market
Table 2. Adalimumab Drug Market Drivers in Global Market
Table 3. Adalimumab Drug Market Restraints in Global Market
Table 4. Key Players of Adalimumab Drug in Global Market
Table 5. Top Adalimumab Drug Players in Global Market, Ranking by Revenue (2024)
Table 6. Global Adalimumab Drug Revenue by Companies, (US$, Mn), 2020-2025
Table 7. Global Adalimumab Drug Revenue Share by Companies, 2020-2025
Table 8. Global Companies Adalimumab Drug Product Type
Table 9. List of Global Tier 1 Adalimumab Drug Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Adalimumab Drug Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 11. Segmentation by Type � Global Adalimumab Drug Revenue, (US$, Mn), 2024 & 2032
Table 12. Segmentation by Type - Global Adalimumab Drug Revenue (US$, Mn), 2020-2025
Table 13. Segmentation by Type - Global Adalimumab Drug Revenue (US$, Mn), 2026-2032
Table 14. Segmentation by Application� Global Adalimumab Drug Revenue, (US$, Mn), 2024 & 2032
Table 15. Segmentation by Application - Global Adalimumab Drug Revenue, (US$, Mn), 2020-2025
Table 16. Segmentation by Application - Global Adalimumab Drug Revenue, (US$, Mn), 2026-2032
Table 17. By Region� Global Adalimumab Drug Revenue, (US$, Mn), 2024 & 2032
Table 18. By Region - Global Adalimumab Drug Revenue, (US$, Mn), 2020-2025
Table 19. By Region - Global Adalimumab Drug Revenue, (US$, Mn), 2026-2032
Table 20. By Country - North America Adalimumab Drug Revenue, (US$, Mn), 2020-2025
Table 21. By Country - North America Adalimumab Drug Revenue, (US$, Mn), 2026-2032
Table 22. By Country - Europe Adalimumab Drug Revenue, (US$, Mn), 2020-2025
Table 23. By Country - Europe Adalimumab Drug Revenue, (US$, Mn), 2026-2032
Table 24. By Region - Asia Adalimumab Drug Revenue, (US$, Mn), 2020-2025
Table 25. By Region - Asia Adalimumab Drug Revenue, (US$, Mn), 2026-2032
Table 26. By Country - South America Adalimumab Drug Revenue, (US$, Mn), 2020-2025
Table 27. By Country - South America Adalimumab Drug Revenue, (US$, Mn), 2026-2032
Table 28. By Country - Middle East & Africa Adalimumab Drug Revenue, (US$, Mn), 2020-2025
Table 29. By Country - Middle East & Africa Adalimumab Drug Revenue, (US$, Mn), 2026-2032
Table 30. Cambridge Antibody Technology Corporate Summary
Table 31. Cambridge Antibody Technology Adalimumab Drug Product Offerings
Table 32. Cambridge Antibody Technology Adalimumab Drug Revenue (US$, Mn) & (2020-2025)
Table 33. Cambridge Antibody Technology Key News & Latest Developments
Table 34. BASF Corporate Summary
Table 35. BASF Adalimumab Drug Product Offerings
Table 36. BASF Adalimumab Drug Revenue (US$, Mn) & (2020-2025)
Table 37. BASF Key News & Latest Developments
Table 38. AbbVie Corporate Summary
Table 39. AbbVie Adalimumab Drug Product Offerings
Table 40. AbbVie Adalimumab Drug Revenue (US$, Mn) & (2020-2025)
Table 41. AbbVie Key News & Latest Developments
Table 42. MABURA Corporate Summary
Table 43. MABURA Adalimumab Drug Product Offerings
Table 44. MABURA Adalimumab Drug Revenue (US$, Mn) & (2020-2025)
Table 45. MABURA Key News & Latest Developments
Table 46. Exemptia Corporate Summary
Table 47. Exemptia Adalimumab Drug Product Offerings
Table 48. Exemptia Adalimumab Drug Revenue (US$, Mn) & (2020-2025)
Table 49. Exemptia Key News & Latest Developments
Table 50. Amgen Corporate Summary
Table 51. Amgen Adalimumab Drug Product Offerings
Table 52. Amgen Adalimumab Drug Revenue (US$, Mn) & (2020-2025)
Table 53. Amgen Key News & Latest Developments
Table 54. Sandoz Corporate Summary
Table 55. Sandoz Adalimumab Drug Product Offerings
Table 56. Sandoz Adalimumab Drug Revenue (US$, Mn) & (2020-2025)
Table 57. Sandoz Key News & Latest Developments
Table 58. Boehringer Ingelheim Corporate Summary
Table 59. Boehringer Ingelheim Adalimumab Drug Product Offerings
Table 60. Boehringer Ingelheim Adalimumab Drug Revenue (US$, Mn) & (2020-2025)
Table 61. Boehringer Ingelheim Key News & Latest Developments
Table 62. Mylan Corporate Summary
Table 63. Mylan Adalimumab Drug Product Offerings
Table 64. Mylan Adalimumab Drug Revenue (US$, Mn) & (2020-2025)
Table 65. Mylan Key News & Latest Developments
Table 66. Biogen Corporate Summary
Table 67. Biogen Adalimumab Drug Product Offerings
Table 68. Biogen Adalimumab Drug Revenue (US$, Mn) & (2020-2025)
Table 69. Biogen Key News & Latest Developments
List of Figures
Figure 1. Adalimumab Drug Product Picture
Figure 2. Adalimumab Drug Segment by Type in 2024
Figure 3. Adalimumab Drug Segment by Application in 2024
Figure 4. Global Adalimumab Drug Market Overview: 2024
Figure 5. Key Caveats
Figure 6. Global Adalimumab Drug Market Size: 2024 VS 2032 (US$, Mn)
Figure 7. Global Adalimumab Drug Revenue: 2020-2032 (US$, Mn)
Figure 8. The Top 3 and 5 Players Market Share by Adalimumab Drug Revenue in 2024
Figure 9. Segmentation by Type � Global Adalimumab Drug Revenue, (US$, Mn), 2024 & 2032
Figure 10. Segmentation by Type - Global Adalimumab Drug Revenue Market Share, 2020-2032
Figure 11. Segmentation by Application � Global Adalimumab Drug Revenue, (US$, Mn), 2024 & 2032
Figure 12. Segmentation by Application - Global Adalimumab Drug Revenue Market Share, 2020-2032
Figure 13. By Region - Global Adalimumab Drug Revenue Market Share, 2020-2032
Figure 14. By Country - North America Adalimumab Drug Revenue Market Share, 2020-2032
Figure 15. United States Adalimumab Drug Revenue, (US$, Mn), 2020-2032
Figure 16. Canada Adalimumab Drug Revenue, (US$, Mn), 2020-2032
Figure 17. Mexico Adalimumab Drug Revenue, (US$, Mn), 2020-2032
Figure 18. By Country - Europe Adalimumab Drug Revenue Market Share, 2020-2032
Figure 19. Germany Adalimumab Drug Revenue, (US$, Mn), 2020-2032
Figure 20. France Adalimumab Drug Revenue, (US$, Mn), 2020-2032
Figure 21. U.K. Adalimumab Drug Revenue, (US$, Mn), 2020-2032
Figure 22. Italy Adalimumab Drug Revenue, (US$, Mn), 2020-2032
Figure 23. Russia Adalimumab Drug Revenue, (US$, Mn), 2020-2032
Figure 24. Nordic Countries Adalimumab Drug Revenue, (US$, Mn), 2020-2032
Figure 25. Benelux Adalimumab Drug Revenue, (US$, Mn), 2020-2032
Figure 26. By Region - Asia Adalimumab Drug Revenue Market Share, 2020-2032
Figure 27. China Adalimumab Drug Revenue, (US$, Mn), 2020-2032
Figure 28. Japan Adalimumab Drug Revenue, (US$, Mn), 2020-2032
Figure 29. South Korea Adalimumab Drug Revenue, (US$, Mn), 2020-2032
Figure 30. Southeast Asia Adalimumab Drug Revenue, (US$, Mn), 2020-2032
Figure 31. India Adalimumab Drug Revenue, (US$, Mn), 2020-2032
Figure 32. By Country - South America Adalimumab Drug Revenue Market Share, 2020-2032
Figure 33. Brazil Adalimumab Drug Revenue, (US$, Mn), 2020-2032
Figure 34. Argentina Adalimumab Drug Revenue, (US$, Mn), 2020-2032
Figure 35. By Country - Middle East & Africa Adalimumab Drug Revenue Market Share, 2020-2032
Figure 36. Turkey Adalimumab Drug Revenue, (US$, Mn), 2020-2032
Figure 37. Israel Adalimumab Drug Revenue, (US$, Mn), 2020-2032
Figure 38. Saudi Arabia Adalimumab Drug Revenue, (US$, Mn), 2020-2032
Figure 39. UAE Adalimumab Drug Revenue, (US$, Mn), 2020-2032
Figure 40. Cambridge Antibody Technology Adalimumab Drug Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 41. BASF Adalimumab Drug Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 42. AbbVie Adalimumab Drug Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 43. MABURA Adalimumab Drug Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 44. Exemptia Adalimumab Drug Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 45. Amgen Adalimumab Drug Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 46. Sandoz Adalimumab Drug Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 47. Boehringer Ingelheim Adalimumab Drug Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 48. Mylan Adalimumab Drug Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 49. Biogen Adalimumab Drug Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
